Locoregional recurrence
Increased expression of SKP2 is an independent predictor of locoregional recurrence in cervical cancer via promoting DNA-damage response after irradiation
15
EZH2 expression correlates with locoregional recurrence after radiation in inflammatory breast cancer
7
<p>Prognosis Value of Platelet Counts, Albumin and Neutrophil-Lymphocyte Ratio of Locoregional Recurrence in Patients with Operable Head and Neck Squamous Cell Carcinoma</p>
11
Mastectomy Scar Boost Results in Low Risk of Locoregional Recurrence in the Setting of Close or Involved Surgical Margins
5
Locoregional recurrence-associated factors and risk-adapted postmastectomy radiotherapy for breast cancer staged in cT1-2N0-1 after neoadjuvant chemotherapy
8
<p>Definitive chemoradiotherapy and salvage chemotherapy for patients with isolated locoregional recurrence after radical resection of primary pancreatic cancer</p>
9
Transbronchial and transesophageal fine-needle aspiration using a single ultrasound bronchoscope in the diagnosis of locoregional recurrence of surgically-treated lung cancer
8
Survival and prognostic factors of non-small cell lung cancer patients with postoperative locoregional recurrence treated with radical radiotherapy
8
Possible influence of mammographic density on local and locoregional recurrence of breast cancer
9
High mammographic breast density predicts locoregional recurrence after modified radical mastectomy for invasive breast cancer: a case control study
9
Postmastectomy locoregional recurrence and recurrence free survival in breast cancer patients
7
Isolated locoregional recurrence patterns of breast cancer after mastectomy and adjuvant systemic therapies in the contemporary era
10
Locoregional recurrence of triple-negative breast cancer: effect of type of surgery and adjuvant postoperative radiotherapy
8
Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy
8
Postmastectomy radiotherapy reduces locoregional and disease recurrence in patients with stage II–III triple-negative breast cancer treated with neoadjuvant chemotherapy and mastectomy
8
Locoregional therapy of breast cancer: maximizing control, minimizing morbidity
19
Applications of radiomics in precision diagnosis, prognostication and treatment planning of head and neck squamous cell carcinomas
19
Exclusive intraoperative radiotherapy for invasive breast cancer in elderly patients (>70 years): proportion of eligible patients and local recurrence-free survival
10
Patterns of failure and survival in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy in Saudi Arabia
7
Role of post mastectomy radiation therapy in breast cancer patients with T1–2 and 1–3 positive lymph nodes
9